Display options
Share it on

Intractable Rare Dis Res. 2015 Nov;4(4):190-7. doi: 10.5582/irdr.2015.01035.

Multiplex cytokine analysis of Werner syndrome.

Intractable & rare diseases research

Makoto Goto, Koichiro Hayata, Junji Chiba, Masaaki Matsuura, Sachiko Iwaki-Egawa, Yasuhiro Watanabe

Affiliations

  1. Division of Anti-ageing and Longevity Sciences, Department of Medical Technology, Faculty of Medical Engineering, Toin University of Yokohama, Yokohama, Japan ; Department of Orthopaedics & Rheumatology, East Medical Center, Tokyo Women's Medical University, Tokyo, Japan ; Division of Rheumatology, Nerima-Hikarigaoka Hospital, Tokyo, Japan.
  2. Department of Orthopaedics & Rheumatology, East Medical Center, Tokyo Women's Medical University, Tokyo, Japan.
  3. Department of Cancer Genomics, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan ; Graduate School of Public Health, Teikyo University, Tokyo, Japan.
  4. Department of Life Sciences, School of Pharmacy, Hokkaido Pharmaceutical University, Hokkaido, Japan.

PMID: 26668779 PMCID: PMC4660860 DOI: 10.5582/irdr.2015.01035

Abstract

We reported a minor inflammation-driven ageing (inflammageing) assessed by highly sensitive CRP (hsCRP) in normal individuals and patients with Werner syndrome (WS), followed by an ageing associated Th2-biased cytokine change in normal ageing in the previous papers. To further study the association of hsCRP and 26 cytokines/chemokines in 35 WS patients, a multiple cytokine array system was used in the same serum samples as were examined for hsCRP. The serum levels of Th2 cytokines (IL-4, IL-6, IL-10, and GM-CSF), Th1 products (IL-2, TNFα, IL-12, and IFNγ) and monocyte/macrophage products (MCP-1, basic FGF and G-CSF) in WS were significantly elevated compared with normal ageing. Elevated hsCRP level in WS was significantly correlated with IL-6, IL-12 and VEGF levels, if age and sex were taken into account. A pro-inflammatory cytokine/chemokine circuit-stimulated immunological shift to Th2 in WS was similar to normal ageing. These cytokine/chemokine changes may induce a systemic chronic inflammation monitored by hsCRP, though these immunological changes in WS were more complicated than normal ageing, possibly due to the WS-specific chronic inflammation such as skin ulcer, diabetes mellitus and central obesity with visceral fat deposition. Further study may warrant the pathophysiology of Th2 shift and Th2-biased inflammageing in normal ageing and WS.

Keywords: Ageing; CRP; Werner syndrome; chemokine; cytokine; inflammageing

References

  1. J Interferon Cytokine Res. 1999 Oct;19(10):1179-82 - PubMed
  2. J Immunol. 2002 Dec 15;169(12):7019-25 - PubMed
  3. Arthritis Rheum. 2003 Jun;48(6):1475-7 - PubMed
  4. J Exp Med. 1999 Aug 16;190(4):585-90 - PubMed
  5. Immunity. 2012 Nov 16;37(5):771-83 - PubMed
  6. Mech Ageing Dev. 1984 Nov;28(1):47-55 - PubMed
  7. Nature. 2004 Sep 23;431(7007):405-6 - PubMed
  8. J Transl Med. 2011 Jul 20;9:113 - PubMed
  9. Ann N Y Acad Sci. 2000 Jun;908:244-54 - PubMed
  10. Biosci Trends. 2008 Dec;2(6):218-30 - PubMed
  11. Nat Rev Immunol. 2013 Dec;13(12):875-87 - PubMed
  12. Circ Res. 2004 Oct 29;95(9):858-66 - PubMed
  13. J Immunol. 2007 Sep 15;179(6):3926-36 - PubMed
  14. Int J Obes (Lond). 2014 Feb;38(2):170-6 - PubMed
  15. Cytokine. 2006 Apr;34(1-2):32-8 - PubMed
  16. Int Immunol. 2010 May;22(5):347-52 - PubMed
  17. Stroke. 2007 Mar;38(3):911-7 - PubMed
  18. Cytokine. 2007 Aug;39(2):123-9 - PubMed
  19. N Engl J Med. 2004 Dec 16;351(25):2599-610 - PubMed
  20. Stroke. 2006 Jan;37(1):27-32 - PubMed
  21. Exp Gerontol. 2012 Dec;47(12):936-9 - PubMed
  22. Immunity. 2004 Nov;21(5):643-53 - PubMed
  23. Circ Res. 2012 Jan 6;110(1):174-89 - PubMed
  24. Immunity. 2007 Sep;27(3):505-17 - PubMed
  25. J Immunol. 1974 Jun;112(6):2135-47 - PubMed
  26. Clin Exp Immunol. 2012 Nov;170(2):186-93 - PubMed
  27. Nat Rev Immunol. 2008 Dec;8(12):958-69 - PubMed
  28. Atherosclerosis. 2008 Jan;196(1):298-305 - PubMed
  29. Gerontology. 2010;56(2):141-9 - PubMed

Publication Types